PRMT5 and prostate carcinoma: Liu Wen et al. confirmed that PRMT4, PRMT5, and PRMT7 were highly expressed in breast cancer, colorectal cancer, and prostate cancer, and the high expression of PRMTs was highly correlated with the enrichment of arginine methylation and abnormal alternative splicing of hnRNPA1.